Network analysis identified GPCR networks, specifically the CXCR3 chemokine axis, as modulators of tumor–immune interactions that may have proliferative effects on primary tumors, as well as a role for immunosurveillance, and may present opportunities for targeted therapy. The gene discussed is CXCR3; the disease is neoplasm.